For example, we have reported the contradicting role of miR-182, as it induced the expression of the activating receptor NKG2D and enhanced NK cell cytotoxicity, hence supporting tumor eradication, while it has also been shown to act as an oncomiR in HCC cells through the inhibition of FOXO3a (24). Here, KLRK1 is linked to hepatocellular carcinoma.